Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Director departure
|
|
REVELATION BIOSCIENCES, INC.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/22/2022 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"INDEX TO FINANCIAL STATEMENTS REVELATION BIOSCIENCES, INC. Report of Independent Registered Public Accounting Firm 2 Balance Sheets 3 Statements of Operations 4 Statements of Changes in Stockholders’ Equity 5 Statements of Cash Flows 6 Notes to the Financial Statements 7 1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Revelation Biosciences, Inc. Opinion on the Financial Statements We have audited the accompanying balance sheet of Revelation Biosciences, Inc. as of December 31, 2021 and 2020, the related statements of operations, changes in stockholders’ equity , and cash flows for the year ended December 31, 2021 and the period from May 4, 2020 to December 31, 2020, and the related notes to the financial statements . In our opinion, ...",
"MANAGEMENT’ S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS" |
|
| 04/15/2022 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"INDEX TO FINANCIAL STATEMENTS REVELATION BIOSCIENCES, INC. Report of Independent Registered Public Accounting Firm 2 Balance Sheets 3 Statements of Operations 4 Statements of Changes in Stockholders’ Equity 5 Statements of Cash Flows 6 Notes to the Financial Statements 7 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of Revelation Biosciences, Inc. Opinion on the Financial Statements We have audited the accompanying balance sheet of Revelation Biosciences, Inc. as of December 31, 2021 and 2020, the related statements of operations, changes in stockholders' equity , and cash flows for the year ended December 31, 2021 and the period from May 4, 2020 to December 31, 2020, and the related notes to the financial statements . In our opinion, th...",
"MANAGEMENT’ S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS" |
|
| 03/05/2021 |
8-K/A
| Quarterly results |
|
|